Novo Holdings appoints Chaerhan Chun to the Novo Advisory Group

Chaerhan Chun will be supporting Novo Holdings’ Asia investment activities.

Novo Holdings is pleased to announce the appointment of Chaerhan Chun to the Novo Advisory Group (NAG), an expert panel of senior industry leaders that supports Novo Holdings in analysing and monitoring its life science investments.

Chaerhan Chun is an investment professional with extensive experience in cross-border private equity, corporate development and strategic investments across Asia, Europe and the US. With her deep knowledge of the Southeast Asia region and primary focus on healthcare, life sciences and growth platforms in emerging markets, she brings insights that are highly relevant to Novo Holdings’ investment activities in Asia.

Kasim Kutay, CEO of Novo Holdings, said: “Chaerhan’s contributions will be valuable to the continued expansion of our Asia portfolio, and we look very much forward to working together with her.”

Driving growth and innovation
Chaerhan Chun has extensive experience leading global investments, driving growth, transformation and innovations.

For almost a decade, she has held senior investment and corporate development roles within SK Group – most recently as Head of Vietnam Investments – where she was responsible for originating, structuring, and executing cross-border investments and partnerships. Her experience spans buyouts, minority growth investments and complex carve-outs across Southeast Asia, the US and Europe. She has led transactions from origination through execution and post-investment value creation and is experienced in working with management teams and boards to drive growth and strategic outcomes.

Prior to her time in SK Group, Chaerhan has worked in investment banking in South Korea and the US, including for J.P. Morgan.

Chaerhan Chun is a member of YPO, the global leadership community of extraordinary chief executives.

Chaerhan Chun said: “I am delighted to be appointed as a member of the Novo Advisory Group, which gives me the opportunity to contribute to the continued development of Novo Holdings' Asia portfolio, leveraging my knowledge of the Southeast Asia region and expertise in sourcing and overseeing investments. I look forward to supporting Novo Holdings’ important mission as a life science investor.”

About Chaerhan Chun
Korean citizen

Board experience
Chaerhan has served on the boards of numerous companies, including as Chair of the Boards of Imexpharm and Pharmacity.

Career
2023-2024 Head of Vietnam Investments, SK, Vietnam

2022 Head of SEA Investments, SK, Seoul, South Korea

2019-2021 Head of Healthcare and Sustainable Food Investments, SK, Seoul, South Korea

2016-2018 Project Lead, Healthcare Investment Team, SK, Seoul, South Korea

2015-2016 Investment Banking Associate, Korea, J.P. Morgan, Seoul, South Korea

2013-2015 Investment Banking Associate, Diversified Industries Group, J.P. Morgan, New York, US

2012 Summer Associate, Diversified Industries Group, J.P. Morgan, New York, US

2006-2010 Credit Analyst, Standard Chartered Bank, Seoul, South Korea

2005-2006 Credit Analyst, China Construction Bank, Seoul, South Korea

2003-2005 Assistant Relationship Manager, Union Bank of California, Seoul, South Korea

Education
Chaerhan holds an MBA in Finance from the University of Chicago Booth School of Business and a BA in English Language and Literature from Korea University.